Table 4.

Factors associated with NCD control at 12 months post IC enrolment

Characteristic	Univariate analyses			Multivariate analyses
	ORa	95% CI	p-value	aORb	95% CI	p-value
CD4 count at HIV diagnosis (cells/µL)
< 350	1.00			1.00
≥ 350	0.67	(0.35, 1.27)	0.217	0.59	(0.29, 1.18)	0.138
Time since NCD diagnosis (years)
0–5	1.00			1.00
6–10	0.27	(0.09, 0.83)	0.022	0.35	(0.10, 1.16)	0.087
> 10	0.68	(0.12, 3.79)	0.656	1.42	(0.22, 9.25)	0.716
Good adherence (> 80%)
No	1.00			1.00
Yes	0.47	(0.19, 1.19)	0.112	0.47	(0.16, 1.38)	0.17
Clinic site
Clinic A	1.00
Clinic B	1.56	(0.85, 2.87)	0.150	1.50	(0.71, 3.16)	0.284
Age group (years)
< 40	1.00
40–50	1.14	(0.55, 2.34)	0.729
> 50
Sex
Male	1.00
Female	1.09	(0.58, 2.03)	0.794
Comorbidity
DM	1.00
DMHTN	0.46	(0.06, 3.36)	0.447
HTN	1.00	(0.12, 8.42)	1
BMI category
< 18.5	1.00
18.5–24.9	0.47	(0.026, 8.52)	0.610
25.0–29.9	0.89	(0.05, 15.44)	0.939
≥ 30	0.54	(0.032, 8.90)	0.666
WHO stage at HIV diagnosis
0	1.00
1	0.78	(0.39, 1.56)	0.483
2	0.94	(0.48, 1.87)	0.866
3	2.03	(0.76, 5.41)	0.157
4
Time on ART (years)
0–5	1.00
6–10	0.96	(0.51, 1.79)	0.896
> 10	1.97	(0.12, 31.99)	0.634
Time since HIV diagnosis (years)
0–5	1.00
6–10	1.26	(0.69, 2.28)	0.443
> 10	1.23	(0.51, 2.96)	0.637

DM Diabetes mellitus, HTN Hypertension, DMHTN Dual diagnosis of hypertension and diabetes mellitus

^aOR = unadjusted odds ratio

^baOR = adjusted odds ratio, p values in bold significant at α = 0.2 level

Bold p values indicated statitistical significance